From October 7 to 8, 2017, the 8th Asia Pacific Congenital and Structural Heart Intervention Symposium 2017 (APCASH 2017) was held at the Hong Kong Convention and Exhibition Center. LifeTech was invited to the conference.
On September 26, 2017, the LAmbre™ LAA Closure System was successfully implanted by Prof. Tao Ling from the Department of Cardiovascular Medicine of Xijing Hospital for the first time.
On September 14, 2017, the China Brand Show Poland 2017 was launched in Warsaw, Poland.
On September 8, 2017, LifeTech successfully held the second seminar on endovascular aortic repair in Xi'an.
2017 CPCS was held in Chongqing from September 1 to 3, 2017.
In August 2017, a team led by Prof. Hua Yimin successfully performed minimally invasive interventional occlusions for congenital heart diseases for more than ten pediatric patients from Ganzi Prefecture, Sichuan Province.
LifeTech Scientific Corporation, the leading supplier of minimally invasive interventional medical devices to treat cardiovascular diseases and its subsidiaries announces its comprehensive financial results as of June 30, 2017 .
Recently, LifeTech participated in SOLACI 2017 on invitation, the biggest South American cardiovascular intervention annual conference.
Recently, First Hospital of Wenzhou Medical University performed its first and the other three LAA closure procedures using the LAmbre™ LAA closure system, all with ideal occlusion effects.
LifeTech is a leading supplier of minimally invasive interventional medical devices to treat cardiovascular diseases.